Trinity Biotech (TRIB) Treasury Shares (2016 - 2025)

Trinity Biotech's Treasury Shares history runs 10 years deep, the most recent figure standing at $24.9 million for Q4 2025.

• In Q4 2025, Treasury Shares changed 0.0% year-over-year to $24.9 million; the TTM figure through Dec 2025 stood at $24.9 million (changed 0.0% YoY), while the FY2025 annual figure was $24.9 million, changed 0.0% from the prior year.
• Treasury Shares came in at $24.9 million for Q4 2025 at Trinity Biotech, up from -$24.9 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $24.9 million in Q4 2024 to a low of -$24.9 million in Q1 2021.
• A 5-year average of -$17.3 million and a median of -$24.9 million in 2021 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares changed 0.0% in 2021 and surged 150.38% in 2023, its largest moves.
• Trinity Biotech's Treasury Shares stood at -$24.9 million in 2021, then changed by 0.0% to -$24.9 million in 2022, then soared by 150.38% to $12.6 million in 2023, then jumped by 98.49% to $24.9 million in 2024, then changed by 0.0% to $24.9 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $24.9 million, -$24.9 million, and $24.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison